DES the year in review: controversies

Scot Garg, Fatma Bektas, PWJC (Patrick) Serruys

Research output: Contribution to journalArticleAcademic

2 Citations (Scopus)


Drug-eluting stents (DES) have transformed interventional cardiology over the past decade. Whilst their efficacy has rarely been called into question, there have been concerns over the safety of the early devices, which has prompted the development of new coronary stents. Many of these new devices have entered clinical practice, however questions remain as to whether they offer the improvements in clinical outcomes that were originally anticipated. In addition, there is a debate whether the reported high efficacy of these devices enables percutaneous coronary intervention (PCI) to be performed in patient and lesion sub-groups previous entirely the domain of the cardiac surgeon. This review paper addresses these outstanding questions.
Original languageUndefined/Unknown
Pages (from-to)99-123
Number of pages25
JournalMinerva Cardioangiologica
Issue number2
Publication statusPublished - 2013

Cite this